Rates of suppression and recovery of human sperm output in testosterone-based hormonal contraceptive regimens

Human Reproduction

Volumn 20, Issue 6, 2005, Pages 1733-1740

  Ly, Lam P ^a   Liu, Peter Y ^a   Handelsman, David J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Androgen; Contraception; Progestin; Sperm output; Testosterone

Indexed keywords

ANDROGEN; GESTAGEN; MALE CONTRACEPTIVE AGENT; MEDROXYPROGESTERONE ACETATE; TESTOSTERONE; TESTOSTERONE ENANTATE;

ARTICLE; AUSTRALIA; CHINESE; CONDOM; CONTRACEPTION; CONTROLLED STUDY; FAMILY PLANNING; GEOMETRY; HORMONE RELEASE; HUMAN; MALE; MALE FERTILITY; MALE STERILIZATION REVERSAL; PREGNANCY; QUANTITATIVE ANALYSIS; SEMEN ANALYSIS; SPERMATOGENESIS; SPERMATOZOON DENSITY; VASECTOMY; WORLD HEALTH ORGANIZATION;

EID: 20744450620     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh834     Document Type: Article

References (54)

1. Amann RP and Howards SS (1980) Daily spermatozoal production and epididymal spermatozoal reserves of the human male. J Urol 124, 211-215.
2. Andersen AG, Jensen TK, Carlsen E, Jorgensen N, Andersson AM, Krarup T, Keiding N and Skakkebaek NS (2000) High frequency of sub-optimal semen quality in an unselected population of young men. Hum Reprod 15,366-372.
3. Anderson RA and Baird DT (2002) Male contraception. Endocr Rev 23, 735-762.
4. Barone MA, Nazerali H, Cortes M, Chen-Mok M, Pollack AE and Sokal D (2003) A prospective study of time and number of ejaculations to azoospermia after vasectomy by ligation and excision. J Urol 170,892-896.
5. Barone MA, Irsula B, Chen-Mok M and Sokal DC (2004) Effectiveness of vasectomy using cautery. Biomedcentral Urol 4,10.
6. Berman NG, Wang C and Paulsen CA (1996) Methodological issues in the analysis of human sperm concentration data. J Androl 17,68-73.
7. 2+ influx and the acrosome reaction in human sperm. Cell Signal 5, 531-538.
8. Blackmore PF, Fisher JF, Spilman CH and Bleasdale JE (1996) Unusual steroid specificity of the cell surface progesterone receptor on human sperm. Mol Pharmacol 49,727-739.
9. Bland JM and Altman DG (1994) Regression towards the mean. Br Med J 308,1499.
10. Bonde JP, Ernst E, Jensen TK et al. (1998) Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners. Lancet 352,1172-1177.
11. Chia SE, Tay SK and Lim ST (1998) What constitutes a normal seminal analysis? Semen parameters of 243 fertile men. Hum Reprod 13, 3394-3398.
12. Cohn BA, Overstreet JW, Fogel RJ, Brazil CK, Baird DD and Cirillo PM (2002) Epideiologic studies of human semen quality: considerations for study design. Am J Epidemiol 155,664-671.
13. de Kretser DM and Kerr JB (1994) The cytology of the testis. In Knobil E and Neill JD (eds) The Physiology of Reproduction, 2nd edn. Raven Press, New York, pp. 1177-1290.
14. El-Hefhawy T, Manna PR, Lucom M, Baldi E, Slotte JP and Hubtaniemi I (2000) Progesterone action in a murine Leydig tumor cell line (mLTC-1), possibly through a nonclassical receptor type. Endocrinology 141, 247-255.
15. Gu YQ, Wang XH, Xu D, Peng L, Cheng LF, Huang MK, Huang ZJ and Zhang GY (2002) A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men. J Clin Endocrinol Metab 88,562-568.
16. Guzick DS, Overstreet JW, Factor-Litvak P et al. (2001) Sperm morphology, motility, and concentration in fertile and infertile men. New Engl J Med 345,1388-1393.
17. Handelsman DJ (1997) Sperm output of healthy men in Australia: magnitude of bias due to self-selected volunteers. Hum Reprod 12,2701-2705.
18. Handelsman DJ (2001) Estrogens and falling sperm counts. Reprod Fertil Dev 13,317-324.
19. Handelsman DJ (2002) Optimal power transformations for analysis of sperm concentration and other semen variables. J Androl 23,629-634.
20. Handelsman DJ (2005) Male contraception. In DeGroot LJ (ed.) Endocrinology, 5th edn. WB Saunders, Philadelphia, (in press).
21. Handelsman DJ, Conway AJ and Boylan LM (1992) Suppression of human spermatogenesis by testosterone implants in man. J Clin Endocrinol Metab 75,1326-1332.
22. Handelsman DJ, Conway AJ, Howe CJ, Tamer L and Mackey MA (1996) Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot. J Clin Endocrinol Metab 81,4113-4121.
23. Handelsman DJ, Spaliviero JA, Simpson JM, Allan CM and Singh J (1999) Spermatogenesis without gonadotropins: maintenance has a lower testosterone threshold than initiation. Endocrinology 140,3938-3946.
24. Holman CD, Wisniewski ZS, Sernmens JB, Rouse IL and Bass AJ (2000) Population-based outcomes after 28,246 in-hospital vasectomies and 1,902 vasovasostomies in Western Australia. Br J Urol lnt 86,1043-1049.
25. Johnson L and Varner DD (1988) Effect of daily spermatozoan production but not age on transit time of spermatozoa through the human epididymis. Biol Reprod 39,812-817.
26. Kamischke A and Nieschlag E (2004) Progress towards hormonal male contraception. Trends Pharmacol Sci 25,49-57.
27. Kamischke A, Ploger D, Venherm S, von Eckardstein S, von Eckardstein A and Nieschlag E (2000) Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception. Clin Endocrinol (Oxf) 53,43-52.
28. Kaunitz AM (1994) Long-acting injectable contraception with depot medroxyprogesterone acetate. Am J Obstet Gynecol 170,1543-1549.
29. Lan PT, Aedo AR, Landgren BM, Johannisson E and Diczfalusy E (1984) Return of ovulation following a single injection of depo-medroxyprogesterone acetate: a pharmacokinetic and pharmacodynamic study. Contraception 29,1-18.
30. Lemcke B, Behre HM and Nieschlag E (1997) Frequently subnormal semen semen profiles of normal volunteers recruited over 17 years. Int J Androl. 20,144-152.
31. Luconi M, Bonaccorsi L, Maggi M, Pecchioli P, Krausz C, Forti G and Baldi E (1998) Identification and characterization of functional non-genornic progesterone receptors on human sperm membrane. J Clin Endocrinol Metab 83,877-885.
32. MacLeod J and Gold RZ (1951) The male factor in fertility and infertility. II. Spermatozoan counts in 1000 men of known fertility and in 1000 cases of infertile marriage. J Urol 66,436-439.
33. McLachlan RI, O'Donnell L, Stanton PG, Balourdos G, Frydenberg M, de Kretser DM and Robertson DM (2002) Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men. J Clin Endocrinol Metab 87,546-556.
34. McLachlan RI, Robertson DM, Pruysers E, Ugoni A, Matsumoto AM, Anawalt BD, Bremner WJ and Meriggiola C (2004) Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment. J Clin Endocrinol Metab 89,142-149.
35. Meistrich ML and Brown CC (1983) Estimation of the increased risk of human infertility from alterations in semen characteristics. Fertil Steril 40,220-230.
36. Meriggiola. MC, Costantino A, Bremner WJ and Morselli-Labate AM (2002) Higher testosterone dose impairs sperm suppression induced by a combined androgen-progestin regimen. J Androl 23,684-690.
37. Michel E, Bents H, Akhtar FB, Honigl W, Knuth UA, Sandow J and Nieschlag E (1985) Failure of high-dose sustained release luteinizing hormone releasing hormone agonist (buserelin) plus oral testosterone to suppress male fertility. Clin Endocrinol (Oxf) 23,663-675.
38. Mishell DR (1996) Pharmacokinetics of depot medroxyprogesterone acetate contraception. J Reprod Med 41,381-390.
39. Ombelet W, Bosmans E, Janssen M et al. (1997) Semen parameters in a fertile versus subfertile population: a need for change in the interpretation of semen testing. Hum Reprod 12,987-993.
40. Ortiz A, Hirol M, Stanczyk FZ, Goebelsmann U and Mishell DR (1977) Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA. J Clin Endocrinol Metab 44,32-38.
41. Pino AM and Valladares LE (1988) Evidence for a Leydig cell progesterone receptor in the rat. J Steroid Biochem 29,709-714.
42. Rowley MJ, Teshima F and Heller CG (1970) Duration of transit of spermatozoa through the human male ductular system. Fertil Steril 21,390-396.
43. Schwartz D, Laplanche A, Jouannet P and David G (1979) Within-subject variability of human semen in regard to sperm count, volume, total number of spermatozoa and length of abstinence. J Reprod Fertil 57,391-395.
44. Schwingl PJ and Guess HA (2000) Safety and effectiveness of vasectomy. Fertil Steril 73,923-936.
45. Sokal D, Irsula B, Hays M, Chen-Mok M and Barone MA (2004) Vasectomy by ligation and excision, with or without fascial interposition: a randomized controlled trial. Biomedcentral Med 2,6.
46. Turner L, Conway AJ, Jimenez M, Liu PY, Forbes E, McLachlan RI and Handelsman DJ (2003) Contraceptive efficacy of a depot progestin and androgen combination in men. J Clin Endocrinol Metab 88,4659-4667.
47. von Eckardstein S, Noe G, Brache V et al. (2003) A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men. J Clin Endocrinol Metab 88,5232-5239.
48. WHO Task Force on Methods for the Regulation of Male Fertility (1990) Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 336,955-959.
49. WHO Task Force on Methods for the Regulation of Male Fertility (1996) Contraceptive efficacy of testosterone-induced azoospermia. and oligozoospermia in normal men. Fertil Steril 65,821-829.
50. Williams K, Saunders PT, Atanassova N, Fisher JS, Turner KJ, Millar MR, McKinnell C and Sharpe RM (2000) Induction of progesterone receptor immunoexpression in stromal. tissue throughout the male reproductive tract after neonatal oestrogen treatment of rats. Mol Cell Endocrinol 164,117-131.
51. Worgul T, Baker HWG, Murray FT, Jefferson LS and Bardin CW (1979) Direct effects of medroxyprogesterone acetate on testes: possible mechanisms examined by testicular perfusion. Int J Androl 2,408-418.
52. Zhang FP, Pakarainen T, Poutanen M, Toppari J and Huhtanierni I (2003) The low gonadotropin-independent constitutive production of testicular testosterone is sufficient to maintain spermatogenesis. Proc Natl Acad Sci USA 100,13692-13697.
53. Zhang GY, Go YQ, Wang XH, Cui YG and Bremner WJ (1999) A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men. J Clin Endocrinol Metab 84,3642-3647.
54. Zinaman MJ, Brown CC, Selevan SG and Clegg ED (2000) Semen quality and human fertility: a prospective study with healthy couples. J Androl 21, 145-153.